ERBB2-ERBB4 signaling pathway

pathway activity — cross-omics
GO:0038135Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the ERBB2-ERBB4 signaling pathway pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are ERBB2, PGAP3, and TIAL1, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, ERBB2-ERBB4 signaling pathway activity versus ERBB2 in BRCA (Pearson r = 0.58).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCAERBB2 →+1.281+0.672<.001<.00135
BRCAPGAP3 →+0.959+0.552<.001<.00134
GBMTIAL1 →-0.277-0.251.001.00134
GBMZBTB8B →-0.434-0.210.004.00734
OVRFC4 →-0.638-0.412.001.00133
COADATPAF2 →-0.256-0.361.003.00824
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0038135 vs ERBB2 — BRCA

Per-sample scatter of ERBB2-ERBB4 signaling pathway activity vs ERBB2 in BRCA.

Explore this scatter interactively →

Exploration